Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Muscle-invasive bladder cancer

  • You have access
    Nucleoporin 188 as a Predictive Biomarker of Poor Prognosis in Muscle-invasive Bladder Cancer
    MINGXING ZHENG, JIANMING LU, WENSHI YU, YAXIAN LI, YONGLU WU, YUHUI YAO, HUIZHEN TIAN, LIANGLIANG HUANG, LE ZHANG and JUNHONG DENG
    Anticancer Research August 2025, 45 (8) 3245-3261; DOI: https://doi.org/10.21873/anticanres.17686
  • You have access
    Muscle–Invasive Bladder Cancer With Hydronephrosis Exhibits a High Frequency of Mutations in Fibroblast Growth Factor Receptor 3 Gene
    KOHEI KOBATAKE, KENICHIRO IKEDA, YUKI KOHADA, RYO TASAKA, KENSHIRO TAKEMOTO, TAKAFUMI FUKUSHIMA, SHUNSUKE MIYAMOTO, YOHEI SEKINO, HIROYUKI KITANO, KEISUKE GOTO, KEISUKE HIEDA, AKIHIRO GORIKI, TETSUTARO HAYASHI and NOBUYUKI HINATA
    Anticancer Research May 2024, 44 (5) 1947-1954; DOI: https://doi.org/10.21873/anticanres.16997
  • You have access
    Nuclear Factor IA Is Down-regulated in Muscle-invasive and High-grade Bladder Cancers
    MACIEJ KACZOROWSKI, JOANNA MATYSIAK, PAWEL KIELB, BARTOSZ MALKIEWICZ and AGNIESZKA HALON
    Anticancer Research January 2022, 42 (1) 493-500; DOI: https://doi.org/10.21873/anticanres.15507
  • You have access
    Clinicopathological Profiling of LC3B, an Autophagy Marker, and ESRRA (Estrogen-related Receptor-alpha) in Muscle-invasive Bladder Cancer
    SUP KIM, ADAM JAEHYEOK LEE, MIN-KYUNG YEO, YONG GIL NA, JI-YEON KIM, MOON-JUNE CHO, JUN-SANG KIM, EUN-KYEONG JO and JIN-MAN KIM
    Anticancer Research April 2018, 38 (4) 2429-2437;
  • You have access
    Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients
    DEEPAK KILARI, KENNETH A. ICZKOWSKI, CHINTAN PANDYA, ADAM J. ROBIN, EDWARD M. MESSING, ELIZABETH GUANCIAL and ERIC S. KIM
    Anticancer Research February 2016, 36 (2) 495-501;
  • You have access
    Retrospective Analysis of the Efficacy of Two Cycles of M-VAC Neoadjuvant Chemotherapy Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer
    YASUHIDE KITAGAWA, KOUJI IZUMI, SOTARO MIWA, YOSHIFUMI KADONO, HIROYUKI KONAKA, ATSUSHI MIZOKAMI and MIKIO NAMIKI
    Anticancer Research October 2013, 33 (10) 4497-4503;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire